0O1O Stock Overview
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 0O1O from our risk checks.
Vetoquinol SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €97.90 |
| 52 Week High | €108.99 |
| 52 Week Low | €76.60 |
| Beta | 0.91 |
| 1 Month Change | -4.94% |
| 3 Month Change | -7.99% |
| 1 Year Change | 11.25% |
| 3 Year Change | -11.64% |
| 5 Year Change | 69.67% |
| Change since IPO | 276.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0O1O | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 1.1% | 2.5% | 0.4% |
| 1Y | 11.3% | -3.7% | -1.0% |
Return vs Industry: 0O1O exceeded the UK Pharmaceuticals industry which returned -3.7% over the past year.
Return vs Market: 0O1O exceeded the UK Market which returned -1% over the past year.
Price Volatility
| 0O1O volatility | |
|---|---|
| 0O1O Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 8.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0O1O has not had significant price volatility in the past 3 months.
Volatility Over Time: 0O1O's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1933 | 2,497 | Matthieu Frechin | www.vetoquinol.com |
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France.
Vetoquinol SA Fundamentals Summary
| 0O1O fundamental statistics | |
|---|---|
| Market cap | €1.16b |
| Earnings (TTM) | €55.60m |
| Revenue (TTM) | €529.30m |
20.8x
P/E Ratio2.2x
P/S RatioIs 0O1O overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0O1O income statement (TTM) | |
|---|---|
| Revenue | €529.30m |
| Cost of Revenue | €0 |
| Gross Profit | €529.30m |
| Other Expenses | €473.70m |
| Earnings | €55.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 12, 2024
| Earnings per share (EPS) | 4.70 |
| Gross Margin | 100.00% |
| Net Profit Margin | 10.50% |
| Debt/Equity Ratio | 3.1% |
How did 0O1O perform over the long term?
See historical performance and comparison